Van Le

Q: What is Van Le email address?

Email Van Le at van.le@abbott.com. This email is the most updated Van Le email found in 2026.

Q: How to contact Van Le?

To contact Van Le send an email to van.le@abbott.com. (updated on September 13, 2024)

BD&L Manager at Novartis | Vietnam

About Van Le

As a Business Development and Licensing (BD&L) Manager at Novartis, Van Le plays a pivotal role in driving the company's Innovative Medicines performance through strategic out-licensing initiatives and effective alliance management. With a robust background in B2B sales and account management, Van leverages exceptional client service skills to foster strong partnerships that enhance value creation. His academic foundation, with a Bachelor of Science in Biotechnology from Nottingham University and a Master's degree in Biotechnology and Entrepreneurship, equips him with a unique blend of scientific knowledge and business acumen, essential for navigating the complexities of the pharmaceutical landscape.

In his current role, Van is responsible for delivering critical financial and strategic insights that inform long-term forecasting and strategic planning. His expertise in business analysis and market research enables him to identify emerging opportunities and assess potential risks, ensuring that Novartis remains at the forefront of innovation. Van's leadership skills are instrumental in guiding cross-functional teams through the intricacies of contract negotiation and project management, fostering a collaborative environment that drives results.

Key projects under his leadership have included the successful negotiation of licensing agreements that expand Novartis' portfolio and enhance its competitive edge in the market. His commitment to professional growth and continuous improvement is evident in his proactive approach to problem-solving and communication, allowing him to adapt to the ever-evolving demands of the industry. With a passion for advancing healthcare solutions, Van Le is dedicated to making a meaningful impact at Novartis and beyond.

Van Le Work